Please assess the completion status of the following clinical trial:

Trial Title: Study to Evaluate if Neoadjuvant Radiotherapy Improves Recurrence Free Survival in Pancreatic Head Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically confirmed adenocarcinoma of the pancreatic head~* Age ≥ 18 years~* Signed informed consent~* ECOG performance status of 0-2~Exclusion Criteria:~* Curative resection is not feasible or presence of metastatic disease~* Patients not eligible for surgery (ASA ≥ 4)~* Participation in an other clinical trial~* Unable or unwilling to sign the informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Neoadjuvant RTx (Type: EXPERIMENTAL): None
- Surgery (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).